Purchases and Sales Made in Q3 2022 in Virax Biolabs Group LTD (VRAX)
This table provides information about the institutional ownership of Virax Biolabs Group LTD (VRAX) during Q3 2022. The information is specifically focused on institutions that hold shares of Virax Biolabs Group Ltd.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
36.6KNew |
$90.4K - $1.2M
|
36.6K
$65.5K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
12.2KNew |
$30.1K - $401K
|
12.2K
$21.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
8.93KNew |
$22.1K - $294K
|
8.93K
$16K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
649New |
$1.6K - $21.4K
|
649
$1.16K
|
|
|
Nov 08, 2022
Q3 2022
|
Riggs Asset Managment Co. Inc.
|
BUY
|
- |
4New |
$9.88 - $132
|
4
$7.16
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1New |
$2.47 - $32.9
|
1
$1.79
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|